Corvus Pharmaceuticals CRVS Quick ratio
Quick ratio at other companies
Other financials
Where this comes from
Calculated from Corvus Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The official record: Corvus Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Corvus Pharmaceuticals's quick ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Corvus Pharmaceuticals's quick ratio?
- Corvus Pharmaceuticals (CRVS) reported quick ratio of 19.8× in Q1 2026.
- How has Corvus Pharmaceuticals's quick ratio changed year-over-year?
- Corvus Pharmaceuticals's quick ratio increased by 304.2% year-over-year, from 4.9× to 19.8×.
- What is the long-term trend for Corvus Pharmaceuticals's quick ratio?
- Over 5 years (2020 to 2025), Corvus Pharmaceuticals's quick ratio has grown at a 10.7% compound annual growth rate (CAGR), from 3.7× to 6.2×.
- What does quick ratio mean?
- Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.